Vaxxas Announces Initiation of Phase I Clinical Study of First Needle-Free COVID-19 Vaccine (HexaPro) Delivered Using High-Density Microarray Patch (HD-MAP)
Vaxxas holds an exclusive license from The University of Texas at Austin (UTA) to the…
Vaxxas holds an exclusive license from The University of Texas at Austin (UTA) to the…
KAOHSIUNG, TAIWAN - Media OutReach - 8 November 2022 - Deputy Mayor Charles Lin of…
Schneider Electric’s Innovation Summit Hong Kong 2022 addresses the energy and climate challenges and sets…
SHANGHAI and CAMBRIDGE, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB;…
SHENZHEN, China--(BUSINESS WIRE)--#Lidar--RoboSense, a world-leading provider of Smart LiDAR Sensor Systems, held a new product…
Company to host webcast and conference call today at 8:30 a.m. ET MORRISVILLE, N.C., Nov.…
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Electric Vehicle Market by Vehicle Type ; Propulsion Type ; Power Output…
Preclinical data support the clinical potential of Turnstone’s next-generation Selected TIL therapy to improve TIL…
MELBOURNE, Australia--(BUSINESS WIRE)--Hansen Technologies (ASX:HSN), a leading global provider of software and services to the…
AUCKLAND, New Zealand & AUSTIN, Texas--(BUSINESS WIRE)--Packet capture authority Endace today announced EndaceFlow™, a high-performance…